AzTrials
AzTrials

Mobility on the Way to Work and Health-related OutcomesDiNaMo-activeNCT06493006

Promoting Sustainable and Active Mobility Among Employees and Students

An observational study of Mobility on the Way to Work and Health-related Outcomes, run by Hannover Medical School at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the study is to assess health data (heart rate variability, blood pressure, blood glucose, particulate matter pollution) and travel characteristics (length, duration and type of commute) on the way to and from work from members of the universities in Hannover (Germany). Read more about this study

Who is it for?
Ages 18 to 75 yearsHealthy volunteers can take part
How many people
367 participants
Where
1 siteGermany
Study dates
1 Aug 2024to 30 Apr 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Employees and Students of Hannover Medical School, Leibniz University Hannover, University of Applied Sciences and Arts Hannover, and the Leibniz Information Centre for Science and Technology (all Lower Saxony, Germany)

Who may be able to join

  • living within 50km around the workplace

Who cannot join

  • current participation in another interventional study

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Hannover Medical School

    Hanover, Lower Saxony, 20625

Other trials in Germany

About this study

Official title: Impact of Physically Active Versus Passive Way to Work on Physical and Mental Aspects of Health in Members at Hannover Universities: an Observational Study

The aim of the study is to assess health data (heart rate variability, blood pressure, blood glucose, particulate matter pollution) and travel characteristics (length, duration and type of commute) on the way to and from work from members of the universities in Hannover (Germany).

Read the detailed description

Active mobility, (i.e. moving around using the own physical strength) has positive sustainability effects. The physically active way to and from college is a great untapped resources for health promotion. The aim of this sub-project is to examine the way to university in order to assess its effect on individual health depending on the means of transport.

In order to determine the status quo and changes in mobility behavior the investigators will use movement trajectories using smartphone apps or inexpensive trackers in a larger cohort, as well as more specified health measures including overweight status, blood pressure, blood glucose concentration, lack of exercise, particulate matter and risk of accidents in a smaller sub-cohort.

By linking this data with the personal characteristics surveyed in other sub-projects, an evaluation of the individual health status and the expected health benefits depending on the route to work can be created. This represents the database for identifying certain groups of people or status groups who could particularly benefit from targeted promotion of an active commute.

Keywords
commuting to work, active mobility, heart rate variability, sustainable universities

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06493006
Study groupRoleWhat they receive
Long-term groupUniversity members who use mainly one transport mode to get to the work place
Short-term groupUniversity members who alternate their transport habits between physically active and passive commuting

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Heart rate variability (HRV)

    HRV measured by a wearable activity tracker

    Measured: 24 hours on two separate days for the short-term subgroup, and 7 consecutive days for the long-term subgroup

Secondary outcomes (6)
  1. Blood glucose concentration

    Intraindividual difference in blood glucose concentration between active and passive commuting as assessed with continuous blood glucose monitoring (Freestyle Libre 3)

    Measured: 24 hours on two separate days for the short-term subgroup

  2. Work-Ability-Index

    Interindividual difference between work ability as assessed with the Work-Ability-Index-Questionnaire.

    By adding up the points obtained from the questionnaire, scores can range from 7 to 49 points. The lower the score, the greater the discrepancy between the job demands placed on the respondent and their individual ability to cope with them.

    Measured: Once at baseline for both study subgroups

  3. 24 hour blood pressure

    Intraindividual difference in 24 hour arterial blood pressure between active and passive commuting as assessed with 24 hour systolic and diastolic blood pressure monitoring (Boso TM-2450)

    Measured: 24 hours on two separate days for the short-term subgroup

  4. Daily moderate to vigorous physical activity (MVPA) duration

    Interindividual difference in MVPA as assessed with a wearable activity tracker (Garmin Smartwatch Forerunner 55)

    Measured: 7 consecutive days for the long-term subgroup

  5. Health-related quality of life

    Interindividual difference between health-related quality of life as assessed with the Short Form 36 questionnaire. The possible score ranges from 0 to 100 points, with 0 points representing the greatest health impairment, while 100 points indicate no health impairment.

    Measured: Once at baseline for both study subgroups

  6. Particulate matter

    Intraindividual difference in particulate matter concentration between active and passive commuting as assessed with a particulate matter measuring module

    Measured: 24 hours on two separate days for the short-term subgroup

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jul 2024
  2. Study start1 Aug 2024
  3. Primary completion30 Mar 2026
  4. Study completion30 Apr 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
367 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06493006
Sponsor's protocol ID
01UV2301B
Acronym
DiNaMo-active
Status last verified
Nov 2025
First submitted
26 Jun 2024
Last updated
17 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Beyer M, Boyen J, Wussow-Hampel S, Stein L, Schmidt LS, Tegtbur U, Haufe S. Role of commuting characteristics on physical and mental health among members at university institutions (DiNaMo-active): a protocol for an observational study. BMJ Open Sport Exerc Med. 2025 Jun 19;11(2):e002665. doi: 10.1136/bmjsem-2025-002665. eCollection 2025.

    PubMed 40546747

Questions about this trial

What is this clinical trial studying?

An observational study of Mobility on the Way to Work and Health-related Outcomes, run by Hannover Medical School at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Heart rate variability (HRV) (time frame: 24 hours on two separate days for the short-term subgroup, and 7 consecutive days for the long-term subgroup). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06493006, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in